Stuart Holden serves as Executive at UroGen Pharma Ltd., where they oversee executive responsibilities. Since joining the company, Stuart Holden has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 26, 2025 involved exercising options for 2,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 26, 2025 | URGN | $0 | Option Exercise | 2,000 | $N/A | Discretionary |
Stuart Holden currently holds 2,000 shares of UroGen Pharma Ltd. (URGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stuart Holden has been a net neutral trader of URGN stock. They have purchased $0 and sold $0 worth of shares.
Stuart Holden's most recent insider trade was on Nov 26, 2025, when they sold 2,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted